Pharmaceuticals

Lundbeck to establish global innovation hub in Greater Boston and relocate US headquarters

* The new hub in Greater Boston will bring Lundbeck closer to one of the world's leading life sciences ecosystems, strengthening access to science, talent and partnerships. * The move is part of Lundbeck's continued investment in the US, a key market, and will support the company's Focused In...

2026-09-25 15:52 959

Basecamp Research raises $140M to advance AI-designed therapeutics

/C O R R E C T I O N -- Basecamp Research/ In the news release, Basecamp Research raises $140M to advance AI-designed therapeutics, issued 23-Sep-2026 by Basecamp Research over PR Newswire, we are advised by the company that information has changed in the first bulleted subheadline and in the fo...

2026-09-25 01:44 1382

Daewoong Pharmaceutical Presents Baseline Characteristics of 104 Patients in Global Phase 2 Trial for IPF Drug Candidate 'Bersiporocin' at ERS 2026

* 104 IPF patients enrolled in US and South Korea as global Phase 2 trial progresses toward completion * Study includes both antifibrotic-treated and untreated patients; top-line data expected in H1 2027 * First-in-class PRS inhibitor being developed as a potential new therapeutic option...

2026-09-24 08:00 1777

Basecamp Research raises $140M to advance AI-designed therapeutics

* Oversubscribed Series C led by S32 with backing from NVIDIA and others * Funding will advance a pipeline of EDEN-designed therapeutics, starting with in vivo cell therapy, and expand pharmaceutical partnerships * The company has demonstrated strong preclinical results across multiple modal...

2026-09-23 21:00 750

Werfen Announces US FDA 510(k) Clearance and CE Mark for Aptiva® Antiphospholipid Syndrome IgA Reagent

FDA Clearance and CE Mark Complete Aptiva's Antiphospholipid Syndrome Portfolio, Expanding Global Access to Comprehensive APS Testing SAN DIEGO, Sept. 23, 2026 /PRNewswire/ -- Werfen today announced that its Aptiva Antiphospholipid Syndrome (APS) Immunoglobulin A (IgA) Reagent has received both ...

2026-09-23 20:00 985

HKSH Medical Group and United Imaging Mark Launch of Hong Kong's First Long-Axial PET/CT

HONG KONG, Sept. 23, 2026 /PRNewswire/ -- HKSH Medical Group (HKSH) and United Imaging Healthcare (United Imaging) announced on September 23 the arrival of Hong Kong's first long-axial PET/CT, the uMI Panorama GS, at HKSH Cancer Centre, providing a new technology platform for molecular imaging cl...

2026-09-23 18:30 727

Novo receives Singapore approval for Wegovy® as first treatment for MASH with liver fibrosis

ESSENCE trial data showed 63% of participants receiving semaglutide achieved steatohepatitis resolution without worsening of liver fibrosis, compared with 34% receiving placebo, at Week 72. * Singapore's Health Sciences Authority (HSA) has approved Wegovy® (once-weekly injectable semaglutide 2...

2026-09-23 10:05 1866

Kazia Therapeutics Announces Sovargen Co. Doses First Patient in Phase 1b/2a Trial of Paxalisib for Rare Seizure Disorders

Clinical Milestone Expands Development of Paxalisib Beyond Oncology and Triggers $2 Million Payment to Kazia SYDNEY, Sept. 22, 2026 /PRNewswire/ -- Kazia Therapeutics Limited

2026-09-22 19:30 1447

Multiple Sacituzumab Tirumotecan (sac-TMT) Studies Selected as LBAs at ESMO 2026, OptiTROP-Lung04 and OptiTROP-Lung06 to be Presented in the Lung Cancer Session

CHENGDU, China, Sept. 22, 2026 /PRNewswire/ -- The 2026 European Society for Medical Oncology (ESMO) Congress will be held in Madrid, Spain, from October 23 to 27. Multiple Phase III clinical studies of the TROP2 ADC sacituzumab tirumotecan (sac-TMT, also known as SKB264/MK-2870) (佳泰莱®) developed...

2026-09-22 15:48 1130

6 countries across Terumo Asia Pacific officially recognized as Best Workplaces™ Certified by Great Place To Work®

SINGAPORE, Sept. 21, 2026 /PRNewswire/ -- Terumo is proud to announce that 6 countries across Terumo Asia Pacific have officially been recognized as Best Workplaces™ Certified by Great Place To Work®.

2026-09-21 12:00 685

MALAYSIA HEALTHCARE DEEPENS BANGLADESH PRESENCE AS MEDICAL TOURISM DEMAND GROWS

CHATTOGRAM, Bangladesh, Sept. 21, 2026 /PRNewswire/ -- Malaysia Healthcare Travel Council (MHTC) deepened its engagement in Bangladesh through Malaysia Healthcare Week in Bangladesh, held from 16 to 21 September, bringing Malaysian hospitals and healthcare stakeholders together across Dhaka and C...

2026-09-21 10:41 1698

Telix and ITM Join Forces to Create a Radiopharmaceutical Powerhouse

* Transformational merger reinforces Telix's long-term growth strategy as a vertically integrated radiopharmaceutical company with enhanced capabilities across development, isotope production and global manufacturing, underpinned by commercial excellence and the industry's most extensive therap...

2026-09-21 09:59 1648

New Option To Support Cervical Health In Women With HPV In Singapore

Colpofix®, a vaginal spray gel medical device, supports the regression of HPV-related cervical lesions SINGAPORE, Sept. 21, 2026 /PRNewswire/ -- Women in Singapore now have another option to support their cervical health following Human Papillomavirus (HPV) infection, with DKSH's launch of Colpo...

2026-09-21 09:00 1801

Antengene Announces First Patient Dosed in Pivotal Phase III CLINCH-3 Study of ATG-022

SHANGHAI and HONG KONG, Sept. 21, 2026 /PRNewswire/ -- Antengene Corporation Limited ("Antengene", SEHK: 6996.HK), a leading innovative, commercial-stage global biotech company dedicated to discovering, developing and commercializing first-in-class and/or best-in-class medicines for autoimmune di...

2026-09-21 08:30 1206

S2S China Announces 2026 Finalists, Ten Standout Teams Set to Pitch Global Investors at Westlake University

SHANGHAI, Sept. 20, 2026 /PRNewswire/ -- The inaugural S2S China Symposium has announced the finalists of its 2026 program. Co-hosted by RA Capital Management and Qiming Venture Partners, S2S China is the China chapter of Science2Startup, an invitation-only symposium connecting top academic resea...

2026-09-20 20:24 2470

BioShanghai Week 2026 Opens -- Joining Forces to Build a Global Biopharmaceutical Innovation Ecosystem

SHANGHAI, Sept. 20, 2026 /PRNewswire/ -- A news report from Yicai Global: On September 17, the BioShanghai Week 2026 opened at Zhangjiang Science Hall in Shanghai. Themed "AI for Biopharma, Health ...

2026-09-20 13:11 1940

Jiahui Health Highlights China's Growing Role in Global Medical Tourism at WTO Public Forum 2026

GENEVA, Sept. 18, 2026 /PRNewswire/ -- China is seeing growing momentum in inbound medical tourism, driven by expanding access to innovative therapies, visa facilitation and the development of internationally oriented healthcare services, Dr. John K. Hsiang, Chairman of Jiahui Health Executive Co...

2026-09-18 21:00 1860

2026 Tang Prize Award Ceremony Honors Six Laureates

Outstanding Achievements for Global Well-Being and Our Shared Future TAIPEI, Sept. 18, 2026 /PRNewswire/ -- The 2026 Tang Prize Award Ceremony brought together all six laureates in Taipei on September 18, with five receiving their awards in person and Biopharmaceutical Science laureate Dr. Steve...

2026-09-18 19:56 571

A robust adjusted EBIT margin of 18.8%, driven by solid organic revenue growth of 7.4%

PARIS, Sept. 18, 2026 /PRNewswire/ --  Virbac Headquarters, Carros, France * H1 2026 delivered a robust revenue growth of +7.4% and an adjusted EBIT margin of 18.8% at CERS: ○  Revenue growth is coming from both segm...

2026-09-18 00:33 2246

ADVANCION RELEASES 2025 SUSTAINABILITY REPORT: "SAFE BY CHOICE. SUSTAINABLE BY DESIGN."

Advancion's fifth annual report highlights the Company's progress in safety, sustainable innovation and responsible operations BUFFALO GROVE, Ill., Sept. 17, 2026 /PRNewswire/ -- Advancion Corporation ("Advancion" or the "Company"), a global leader in life sciences buffers and proprietary specia...

2026-09-17 23:48 2409
12345 ... 184

Week's Top Stories